News

Nov 11th 2020

Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference


Nov 05th 2020

Koa Health secures over €14m initial funding and spins out of Telefónica’s moonshot factory


More news

#ThinkBigger

 
 
 

Wellington Partners
Life Sciences

A leading European Venture Capital firm investing in early- and growth-stage Life Science companies.

 

Focus

Therapeutics, Medtech, Diagnostics, Digital Health and Biotechnology.

Strong entrepreneurial teams, deep domain knowledge.

Disruptive, innovative tech addressing high unmet medical needs in attractive markets.

 

Scope

Europe, special circumstances US, leader in Germany.

Seed to late-stage, private companies most of the time.

Ticket sizes from €2m up to €20m over the life of the investment.

 

Funds

Managing and investing out of funds WPLS-III, WPLS-IV and WPLS-V.

More than €400m of funds raised dedicated to Life Sciences.

Investment Team with strong clinical, scientific and operational backgrounds.